03:02 PM, 28th Jan 2026
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve To inter alia consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31 2025.